Danaher

Danaher Corporation (NYSE:DHR), founded in 1984, is a global science and technology leader in biotechnology, life sciences, and diagnostics. The company delivers integrated solutions for therapeutic product development and manufacturing, addressing complex challenges in drug development, laboratory analysis, and clinical diagnostics. Danaher provides specialized equipment, consumables, and services to research institutions and manufacturers. Its portfolio includes advanced analytical instrumentation, genomics platforms, microscopy, critical consumables, bioprocess technologies, and manufacturing support systems for therapeutic creation.

Headquartered in Washington, D.C., Danaher operates across 3 locations globally. Learn about Danaher's global headquarters for specific geographic details. The company employs over 10,000 individuals, supporting its extensive operational capabilities. Danaher's life sciences division offers sophisticated tools like mass spectrometers and flow cytometry systems, while its biotechnology segment provides comprehensive bioprocess technologies, including cell culture media development and filtration systems, vital for streamlining therapeutic creation and advancing research.

Danaher competes with industry leaders such as Roper Technologies, ITW, and Dover, solidifying its position in specialized markets. The company's innovation is evident in its diverse product range, supporting critical applications from genomic medicine to industrial filtration. Through its established brands, Danaher addresses demanding scientific and industrial needs. Meet Danaher's team to learn about the leadership driving its strategic initiatives and operational excellence. Its ticker symbol, NYSE:DHR, highlights its status as a publicly traded entity.